So even if we don’t want to think or talk about it, most of us are well aware that about 40 percent of all Americans are now obese. In other words, they have a body mass index (BMI) of 30 kg/m2 or higher. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management | Tagged: BMI, body, index, mass, mortality, weight | Leave a comment »
It is well understood that there is an association between obesity and future risk for prostate cancer-specific mortality among cancer-free men. What has not been so clear is the relationship between obesity and long-term outcomes, post-treatment, among men diagnosed early with localized disease … READ MORE …
Filed under: Living with Prostate Cancer, Management, Risk, Treatment | Tagged: BMI, mortality, obesity, outcomes, overweight, radical prostatectomy | 2 Comments »
The capacity of the average male human to do things that are probably not very good for his health (and to not do things that probably would be good for his health) is considerable. At the most basic level, for example, most of us here in the US don’t eat very wisely and don’t take anything like enough exercise. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: BMI, body, index, mass, progression, risk, weight | 7 Comments »
A new paper in the Journal of the National Cancer Institute has suggested that strict adherence to a four-point healthy lifestyle may be able to lower risk for lethal forms of prostate cancer. … READ MORE …
Filed under: Prevention, Uncategorized | Tagged: BMI, diet, exercise, weight | 11 Comments »
By using data from the prospective SELECT trial (the Selenium and Vitamin E Cancer Prevention Trial, conducted between 2001 and 2011), researchers have been able to suggest that obesity is strongly associated with increased risk for prostate cancer diagnosis among African American males compared to non-Hispanic whites. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: BMI, body mass, Diagnosis, obesity, risk | Leave a comment »
New data appear to suggest that you really don’t want to be diagnosed with high-risk prostate cancer if you are significantly over-weight or obese. … READ MORE …
Filed under: Uncategorized | Tagged: BMI, body mass, Gleason, mortality | 1 Comment »
According to data presented on Tuesday at the American Association for Cancer Research annual meeting in Chicago, body mass index (BMI) at the time of surgery correlates with risk for biochemical recurrence of prostate cancer after first-line treatment with radical prostatectomy. … READ MORE …
Filed under: Diagnosis, Management, Risk | Tagged: BMI, body mass, outcome, radical prostatectomy, risk, surgery | Leave a comment »
Grace Lu-Yao and colleagues have posted an interesting “Beyond the Abstract” commentary on the UroToday web site in relation to recent data about the associations between obesity and prostate cancer in America. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: biopsy, BMI, body mass index, obesity, risk | 2 Comments »
Three reports discussed today address the refinement of risk information in the diagnosis and prognosis of prostate cancer, with specific regard to:
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: BMI, Gleason score, obesity, percent cancer, PSA, tunor volume, upstaging | Leave a comment »
In today’s news reports we cover items on:
Filed under: Diagnosis, Living with Prostate Cancer, Risk | Tagged: adipose, blood loss, BMI, body mass index, DRE, ethnicity, recurrence, religion, risk, smoking | Leave a comment »
In today’s news reports we comment on studies dealing with:
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: BMI, body mass index, EBRT, endorectal balloon, external beam radiation, neoadjuvant hormone therapy, obesity, PSA | Leave a comment »
This morning’s news reports address:
Filed under: Diagnosis, Drugs in development, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: BMI, brachytherapy, EBRT, HIFU, Italy, obesity, picoplatin, Poniard, seminal vesicles | Leave a comment »
With at least a dozen new reports available today, we have chosen to focus only on the most significant, several of which may be of clinical importance now or in the near future. Most of the other items provide minimal new information and can be accessed through the UroToday web site by those who are interested. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: BMI, body mass index, dexamethasone, docetaxel, genetic testing, genetics, laparoscopic surgery, LRP, prior malignancies, RALP | Leave a comment »
Today’s news items include coverage of:
Filed under: Diagnosis, Drugs in development, Management, Treatment | Tagged: biopsy, BMI, outcomes, research, TargetScan | 1 Comment »
THE "NEW" PROSTATE CANCER INFOLINK 